Kyung-Hun Lee

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors

Jayesh Desai, Sanjeev Deva, Jong Seok Lee et al. · Journal for ImmunoTherapy of Cancer · 2020 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts

Deukchae Na, Jeesoo Chae, Sung‐Yup Cho et al. · Nature Communications · 2021 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group

Changhoon Yoo, Hyeon-Su Im, Kyu-pyo Kim et al. · Therapeutic Advances in Medical Oncology · 2019 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim et al. · Clinical and Molecular Hepatology · 2020 · 46 citations · Full text

Medicine, Oncology, Pharmacology +14

Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR

Yoojoo Lim, Sheehyun Kim, Jun-Kyu Kang et al. · Scientific Reports · 2021 · 27 citations · Full text

Medicine, Molecular Genetics, Oncology +17